APA (7th ed.) Citation

AH, S., EA, T., S, B., L, M., K, P., M, M., . . . JP, J. (2022). Anticoagulant Use During Extracorporeal Membrane Oxygenation Using Heparin and Direct Thrombin Inhibitors in COVID-19 and ARDS Patients. The journal of extra-corporeal technology, 54(3), 223. https://doi.org/10.1182/ject-223-234

Chicago Style (17th ed.) Citation

AH, Stammers, Tesdahl EA, Barletti S, Mongero L, Patel K, Mosca M, Sestokas A, Firstenberg MS, and Jacobs JP. "Anticoagulant Use During Extracorporeal Membrane Oxygenation Using Heparin and Direct Thrombin Inhibitors in COVID-19 and ARDS Patients." The Journal of Extra-corporeal Technology 54, no. 3 (2022): 223. https://doi.org/10.1182/ject-223-234.

MLA (9th ed.) Citation

AH, Stammers, et al. "Anticoagulant Use During Extracorporeal Membrane Oxygenation Using Heparin and Direct Thrombin Inhibitors in COVID-19 and ARDS Patients." The Journal of Extra-corporeal Technology, vol. 54, no. 3, 2022, p. 223, https://doi.org/10.1182/ject-223-234.